PRISM BioLab > ニュース > β-catenin signaling inhibitors ICG-001 and C-82 improve fibrosis in preclinical models of endometriosis

β-catenin signaling inhibitors ICG-001 and C-82 improve fibrosis in preclinical models of endometriosis

Published on: 9月 8, 2021

Japanese

ニュース